Patients with HIV and hepatitis B coinfection are at an increased risk for hepatitis D. Patients with hepatitis D have an increased risk for liver-related complications and mortality. Patients ...

The viral illness kills more people in the city than HIV, but antiviral medications may be helping cut its transmission.

Hepatitis D can lead to a host of devastating symptoms and is the most severe form of viral hepatitis. “It's much more aggressive than hepatitis B. Basically, 50%-70% of patients will progress ...

The American Gastroenterology Association (AGA) updated its clinical practice guidelines for managing hepatitis B ...

A hepatitis D infection therefore only occurs as a co-infection with a hepatitis B infection. ‘Hepatitis D exacerbates the existing HBV infection and causes a fire in the liver, so to speak ...

Hepatitis is inflammation of the liver. Though it is most often caused by one of five different viruses (hepatitis A, B, C, D, and E), there are also nonviral causes ...

Brelovitug is designed to neutralize and remove hepatitis B and hepatitis D virions and deplete HBsAg-containing subviral particles, which makes brelovitug a potentially safe and highly efficacious ...

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to brelovitug (BJT-778) for the treatment of chronic hepatitis delta (CHD).

A newly updated clinical practice guideline offers healthcare practitioners vital evidence-based recommendations for managing ...

For patients with hepatitis B virus, alcohol is associated with dose-dependent increased risks for cirrhosis and hepatocellular carcinoma.

Existing treatment criteria for chronic hepatitis B virus (HBV) infection are mainly based on data from observational studies, such as the REVEAL study from Taiwan, which was initiated in the early ...